An extended PCR-RFLP assay for detection of parC, parE and gyrA mutations in fluoroquinolone-resistant Streptococcus pneumoniae

被引:14
作者
Alonso, R
Galimand, M
Courvalin, P
机构
[1] Inst Pasteur, Unite Agents Antibacteriens, F-75724 Paris 15, France
[2] Univ Basque Country, Dept Microbiol Immunol & Parasitol, Vitoria, Spain
关键词
Gram-positive; resistance; detection;
D O I
10.1093/jac/dkh147
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:682 / 683
页数:2
相关论文
共 6 条
[1]   Rapid detection of point mutations of the Neisseria gonorrhoeae gyrA gene associated with decreased susceptibilities to quinolones [J].
Deguchi, T ;
Yasuda, M ;
Nakano, M ;
Ozeki, S ;
Ezaki, T ;
Maeda, SI ;
Saito, I ;
Kawada, Y .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (09) :2255-2258
[2]   MODIFICATION OF ENZYMATICALLY AMPLIFIED DNA FOR THE DETECTION OF POINT MUTATIONS [J].
HALIASSOS, A ;
CHOMEL, JC ;
TESSON, L ;
BAUDIS, M ;
KRUH, J ;
KAPLAN, JC ;
KITZIS, A .
NUCLEIC ACIDS RESEARCH, 1989, 17 (09) :3606-3606
[3]   Fluoroquinolone resistance is a poor surrogate marker for type II topoisomerase mutations in clinical isolates of Streptococcus pneumoniae [J].
Millichap, JJ ;
Pestova, E ;
Siddiqui, F ;
Noskin, GA ;
Peterson, LR .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (07) :2719-2721
[4]   Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections [J].
Ozeki, S ;
Deguchi, T ;
Yasuda, M ;
Nakano, M ;
Kawamura, T ;
Nishino, Y ;
Kawada, Y .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (09) :2315-2319
[5]   Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae [J].
Pan, XS ;
Ambler, J ;
Mehtar, S ;
Fisher, LM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2321-2326
[6]   Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae [J].
Perichon, B ;
Tankovic, J ;
Courvalin, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1166-1167